We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.4%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.6B
AUM Growth
+$2.24B
(+5.5%)
Cap. Flow
-$670M
Cap. Flow
% of AUM
-1.57%
Top 10 Holdings %
Top 10 Hldgs %
15.36%
Holding
2,428
New
206
Increased
703
Reduced
1,198
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$204M |
| 2 |
JPMorgan Chase
JPM
|
+$72.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$67.5M |
| 4 |
Evergy
EVRG
|
+$66.6M |
| 5 |
NVIDIA
NVDA
|
+$58.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$370M |
| 2 |
United Parcel Service
UPS
|
+$364M |
| 3 |
Dominion Energy
D
|
+$172M |
| 4 |
Moderna
MRNA
|
+$125M |
| 5 |
Teladoc Health
TDOC
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.43% |
| 2 | Technology | 20.08% |
| 3 | Consumer Discretionary | 10.99% |
| 4 | Financials | 9.65% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
1176
DELISTED
Akero Therapeutics
AKRO
| $1.19M | ﹤0.01% |
38,617
+38,538
| +48,782% | +$1.35M |
|
1177
First Horizon
FHN
$11.3B
| $1.19M | ﹤0.01% |
125,965
-255,168
| -67% | -$2.4M |
|
1178
Old National Bancorp
ONB
$9.68B
| $1.18M | ﹤0.01% |
93,731
-39,225
| -30% | -$539K |
|
1179
Lincoln Electric
LECO
$13.9B
| $1.17M | ﹤0.01% |
12,704
-1,372
| -10% | -$126K |
|
1180
Kilroy Realty
KRC
$4B
| $1.17M | ﹤0.01% |
22,471
-2,850
| -11% | -$163K |
|
1181
Ametek
AME
$53.2B
| $1.17M | ﹤0.01% |
11,730
-2,967
| -20% | -$287K |
|
1182
Xerox
XRX
$457M
| $1.16M | ﹤0.01% |
61,914
-30,616
| -33% | -$536K |
|
|
SBNY
1183
DELISTED
Signature Bank
SBNY
| $1.16M | ﹤0.01% |
13,997
+868
| +7% | +$86.4K |
|
1184
ITT
ITT
$17.4B
| $1.16M | ﹤0.01% |
19,647
-2,163
| -10% | -$131K |
|
1185
Dow Inc
DOW
$21.7B
| $1.15M | ﹤0.01% |
24,535
+5,839
| +31% | +$262K |
|
1186
Tennant Co
TNC
$1.16B
| $1.14M | ﹤0.01% |
18,931
+118
| +0.6% | +$7.8K |
|
1187
Norfolk Southern
NSC
$71.2B
| $1.14M | ﹤0.01% |
5,338
-584
| -10% | -$117K |
|
|
PDLI
1188
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.14M | ﹤0.01% |
360,775
-61,294
| -15% | -$196K |
|
1189
Cathay General Bancorp
CATY
$4.14B
| $1.14M | ﹤0.01% |
52,354
-103
| -0.2% | -$2.52K |
|
1190
Nice
NICE
$6.18B
| $1.14M | ﹤0.01% |
5,000
| – | – |
|
1191
First Commonwealth Financial
FCF
$2.14B
| $1.13M | ﹤0.01% |
146,485
-153,955
| -51% | -$1.22M |
|
|
CDK
1192
DELISTED
CDK Global, Inc.
CDK
| $1.13M | ﹤0.01% |
25,969
-3,974
| -13% | -$177K |
|
1193
Fulton Financial
FULT
$4.48B
| $1.13M | ﹤0.01% |
121,070
-254,626
| -68% | -$2.5M |
|
1194
1st Source
SRCE
$2.07B
| $1.13M | ﹤0.01% |
36,558
-488
| -1% | -$16.5K |
|
1195
Jones Lang LaSalle
JLL
$15.7B
| $1.13M | ﹤0.01% |
11,773
-1,027
| -8% | -$103K |
|
|
KREF
1196
KKR Real Estate Finance Trust
KREF
$449M
| $1.12M | ﹤0.01% |
67,840
-28,495
| -30% | -$489K |
|
1197
Lightspeed Commerce
LSPD
$1.25B
| $1.12M | ﹤0.01% |
+35,000
| New | +$1.07M |
|
1198
Silgan Holdings
SLGN
$4.08B
| $1.12M | ﹤0.01% |
30,377
+5,181
| +21% | +$190K |
|
1199
TG Therapeutics
TGTX
$8.55B
| $1.11M | ﹤0.01% |
41,652
-356,356
| -90% | -$8.2M |
|
1200
Cousins Properties
CUZ
$4.65B
| $1.11M | ﹤0.01% |
38,831
+8,598
| +28% | +$256K |
|
Similar funds
Federated Hermes's Q3 2020 Portfolio in Review
As of Q3 2020, Federated Hermes held 2,428 positions worth $42.6B, up 5.5% from $40.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q3 2020 filing shows 206 new, 703 increased, 1,198 reduced and 187 closed positions. Its largest new stake was Snowflake: 234,132 shares worth $58.8M. The largest sale was Alibaba, an estimated $370M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q3 2020 buy was Snowflake: 234,132 shares worth $58.8M.
- Federated Hermes added most to Gilead Sciences in Q3 2020, an estimated $204M increase.
- Federated Hermes's biggest Q3 2020 reduction was Alibaba, cutting an estimated $370M.
- Federated Hermes fully exited BP in Q3 2020, selling an estimated $65.1M.
- Federated Hermes's ten largest holdings make up 15% of its $42.6B portfolio in Q3 2020.
- Federated Hermes opened 206 new positions and closed 187 in Q3 2020.
- Federated Hermes's portfolio value rose 5.5% quarter-over-quarter to $42.6B.
Based on Federated Hermes's 13F filing for Q3 2020, filed 12 Nov 2020.